{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:47:12Z","timestamp":1790434032072,"version":"4.1.0"},"reference-count":35,"publisher":"Royal College of Psychiatrists","issue":"4","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":2650,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Psychiatry"],"published-print":{"date-parts":[[2010,10]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The two main constituents of cannabis, cannabidiol and \u03b4\n                      <jats:sup>9<\/jats:sup>\n                      -tetrahydrocannabinol (THC), have opposing effects both pharmacologically and behaviourally when administered in the laboratory. Street cannabis is known to contain varying levels of each cannabinoid.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To study how the varying levels of cannabidiol and THC have an impact on the acute effects of the drug in naturalistic settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>\n                      Cannabis users (\n                      <jats:italic>n<\/jats:italic>\n                      = 134) were tested 7 days apart on measures of memory and psychotomimetic symptoms, once while they were drug free and once while acutely intoxicated by their own chosen smoked cannabis. Using an unprecedented methodology, a sample of cannabis (as well as saliva) was collected from each user and analysed for levels of cannabinoids. On the basis of highest and lowest cannabidiol content of cannabis, two groups of individuals were directly compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Groups did not differ in the THC content of the cannabis they smoked. Unlike the marked impairment in prose recall of individuals who smoked cannabis low in cannabidiol, participants smoking cannabis high in cannabidiol showed no memory impairment. Cannabidiol content did not affect psychotomimetic symptoms, which were elevated in both groups when intoxicated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The antagonistic effects of cannabidiol at the CB\n                      <jats:sub>1<\/jats:sub>\n                      receptor are probably responsible for its profile in smoked cannabis, attenuating the memory-impairing effects of THC. In terms of harm reduction, users should be made aware of the higher risk of memory impairment associated with smoking low-cannabidiol strains of cannabis like \u2018skunk\u2019 and encouraged to use strains containing higher levels of cannabidiol.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1192\/bjp.bp.110.077503","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T18:22:44Z","timestamp":1285870964000},"page":"285-290","source":"Crossref","is-referenced-by-count":258,"title":["Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study"],"prefix":"10.1192","volume":"197","author":[{"given":"Celia J. A.","family":"Morgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e1inne","family":"Schafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom P.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Valerie","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"170","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"key":"S0007125000253129_ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.08.027"},{"key":"S0007125000253129_ref32","doi-asserted-by":"publisher","DOI":"10.1017\/S0033291708004741"},{"key":"S0007125000253129_ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-006-0508-y"},{"key":"S0007125000253129_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/00008877-200509000-00023"},{"key":"S0007125000253129_ref23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300496"},{"key":"S0007125000253129_ref16","volume-title":"Wechsler Test of Adult Reading","author":"Wechsler","year":"2001"},{"key":"S0007125000253129_ref12","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.046649"},{"key":"S0007125000253129_ref7","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1301643"},{"key":"S0007125000253129_ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1300496"},{"key":"S0007125000253129_ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-007-9036-8"},{"key":"S0007125000253129_ref2","volume-title":"Annual Report 2006: The State of the Drugs Problem in Europe","year":"2006"},{"key":"S0007125000253129_ref1","volume-title":"Health Survey Findings for England 2008","year":"2009"},{"key":"S0007125000253129_ref25","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2009.31"},{"key":"S0007125000253129_ref17","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/17.4.555"},{"key":"S0007125000253129_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61162-3"},{"key":"S0007125000253129_ref21","doi-asserted-by":"publisher","DOI":"10.2466\/pr0.1962.10.3.799"},{"key":"S0007125000253129_ref29","article-title":"Amnestic effect of intrahippocampal AM251, a CB1-selective blocker, in the inhibitory avoidance, but not in the open field habituation task, in rats","volume":"83","author":"de Oliveira","year":"2005","journal-title":"Neurobiol Learn Mem"},{"key":"S0007125000253129_ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1992.tb02003.x"},{"key":"S0007125000253129_ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-002-1169-0"},{"key":"S0007125000253129_ref11","volume-title":"Home Office Cannabis Potency Study","author":"Hardwick","year":"2008"},{"key":"S0007125000253129_ref34","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.109.064220"},{"key":"S0007125000253129_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.08.027"},{"key":"S0007125000253129_ref8","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2006000400001"},{"key":"S0007125000253129_ref13","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707442"},{"key":"S0007125000253129_ref9","article-title":"Antianxiety effects of cannabidiol in the elevated plus-maze","volume":"100","author":"Guimares","year":"1990","journal-title":"Psychopharmacology"},{"key":"S0007125000253129_ref30","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.98.2.150"},{"key":"S0007125000253129_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.acn.2008.02.002"},{"key":"S0007125000253129_ref35","doi-asserted-by":"publisher","DOI":"10.1007\/BF00414031"},{"key":"S0007125000253129_ref18","volume-title":"The Rivermead Behavioural Memory Test","author":"Wilson","year":"1985"},{"key":"S0007125000253129_ref19","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/119.3.889"},{"key":"S0007125000253129_ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050503"},{"key":"S0007125000253129_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2008.02.020"},{"key":"S0007125000253129_ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1995.tb02199.x"},{"key":"S0007125000253129_ref26","article-title":"Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"S0007125000253129_ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nature00839"}],"container-title":["British Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007125000253129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T17:27:32Z","timestamp":1556386052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007125000253129\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0007125000253129"],"URL":"https:\/\/doi.org\/10.1192\/bjp.bp.110.077503","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.7833961.8180054","asserted-by":"object"}]},"ISSN":["0007-1250","1472-1465"],"issn-type":[{"value":"0007-1250","type":"print"},{"value":"1472-1465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}